中国药房2012，Vol.23Issue(17)：1537-1539,3.DOI:10.6039/j.issn.1001-0408.2012.17.01
论制药企业新产品研发立项评估
Evaluation of New Product R&D Project in Pharmaceutical Companies
虞忠 1杨春维1
作者信息
- 1. 重庆华邦制药股份有限公司,重庆401121
- 折叠
摘要
Abstract
OBJECTIVE: To provide reference for the evaluation of new product R&D project in pharmaceutical companies. METHODS: The evaluation of new product R&D project were summarized and evaluated according to the experience of authors and case analysis. The evaluation aspects of new R&D projects were interpreted in terms of medical value, market value, technology feasibility, input-output ratio, etc. RESULTS & CONCLUSIONS: New product R&D project should be evaluated in detail completely, objectively and accurately from medical value, market value, technology feasibility, input-output ratio, etc.关键词
制药企业/新产品研发/立项评估Key words
Pharmaceutical company/ New product R&D/ Project evaluation
分类
医药卫生引用本文复制引用
虞忠,杨春维..论制药企业新产品研发立项评估[J].中国药房,2012,23(17):1537-1539,3.
